CRYOPORT, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CRYOPORT, INC. payments for repurchase of common stock for the quarter ending 2025-12-31 was $2.01M.
- CRYOPORT, INC. payments for repurchase of common stock for the quarter ending 2025-09-30 was $3.75M.
- CRYOPORT, INC. payments for repurchase of common stock for the quarter ending 2022-12-31 was $4.61M.
- CRYOPORT, INC. payments for repurchase of common stock for the quarter ending 2022-09-30 was $0.00.
- CRYOPORT, INC. payments for repurchase of common stock for fiscal 2025 was $10.01M.
- CRYOPORT, INC. payments for repurchase of common stock for fiscal 2022 was $37.96M.
- CRYOPORT, INC. payments for repurchase of common stock for fiscal 2021 was $0.00.
- CRYOPORT, INC. payments for repurchase of common stock for fiscal 2020 was $0.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2025-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $10.01M 10-K · filed 2026-03-05 |
| 2025-09-30 | $3.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2022-12-31 | $4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $37.96M 10-K · filed 2025-03-07 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2022-06-30 | $25.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | |
| 2022-03-31 | $8.35M 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $0.00 10-K · filed 2023-02-28 | |
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |